| Moderna (MRNA) |
United States |
$155.195B |
309.21 |
| Bristol Myers Squibb (BMY) |
United States |
$154.015B |
10.25 |
| Amgen (AMGN) |
United States |
$140.237B |
15.01 |
| CSL (CSLLY) |
Australia |
$99.509B |
0.00 |
| Gilead Sciences (GILD) |
United States |
$87.579B |
8.46 |
| BioNTech SE (BNTX) |
Germany |
$84.970B |
61.61 |
| Illumina (ILMN) |
United States |
$72.769B |
104.93 |
| Regeneron Pharmaceuticals (REGN) |
United States |
$62.489B |
17.89 |
| Vertex Pharmaceuticals (VRTX) |
United States |
$51.899B |
20.17 |
| Biogen (BIIB) |
United States |
$50.373B |
13.83 |
| BeiGene (BGNE) |
Cayman Islands |
$31.544B |
0.00 |
| Genmab (GNMSF) |
Denmark |
$30.486B |
6.62 |
| Genmab (GMAB) |
Denmark |
$30.385B |
35.59 |
| Seagen (SGEN) |
United States |
$28.780B |
48.53 |
| Horizon Therapeutics Public (HZNP) |
Ireland |
$22.423B |
28.67 |
| Alnylam Pharmaceuticals (ALNY) |
United States |
$21.018B |
0.00 |
| Bio-Rad Laboratories (BIO.B) |
United States |
$20.768B |
44.27 |
| Bio-Techne Corp (TECH) |
United States |
$18.717B |
98.42 |
| Exact Sciences (EXAS) |
United States |
$17.919B |
0.00 |
| Incyte (INCY) |
United States |
$17.143B |
40.81 |
| SINO PHARMACEUT (SBMFF) |
Hong Kong, SAR China |
$16.250B |
0.00 |
| ARGENX SE-ADR (ARGX) |
Netherlands |
$16.024B |
0.00 |
| BioMarin Pharmaceutical (BMRN) |
United States |
$14.237B |
102.17 |
| Zai Lab (ZLAB) |
China |
$14.001B |
0.00 |
| Novavax (NVAX) |
United States |
$13.972B |
0.00 |
| Repligen (RGEN) |
United States |
$13.675B |
104.21 |
| QIAGEN (QGEN) |
Netherlands |
$11.967B |
20.27 |
| Guardant Health (GH) |
United States |
$11.173B |
0.00 |
| CureVac (CVAC) |
Germany |
$10.194B |
0.00 |
| Intellia Therapeutics (NTLA) |
United States |
$9.459B |
0.00 |
| CRISPR Therapeutics AG (CRSP) |
Switzerland |
$9.252B |
23.76 |
| Mirati Therapeutics (MRTX) |
United States |
$8.399B |
0.00 |
| Fate Therapeutics (FATE) |
United States |
$7.828B |
0.00 |
| Biohaven Pharmaceutical Holding (BHVN) |
United States |
$7.729B |
0.00 |
| Acceleron Pharma (XLRN) |
United States |
$7.467B |
0.00 |
| Ascendis Pharma (ASND) |
Denmark |
$6.594B |
0.00 |
| Legend Biotech (LEGN) |
United States |
$6.484B |
0.00 |
| Denali Therapeutics (DNLI) |
United States |
$6.197B |
222.30 |
| I-Mab (IMAB) |
China |
$6.014B |
0.00 |
| Twist Bioscience (TWST) |
United States |
$5.819B |
0.00 |
| Beam Therapeutics (BEAM) |
United States |
$5.777B |
0.00 |
| Halozyme Therapeutics (HALO) |
United States |
$5.738B |
31.48 |
| Ultragenyx Pharmaceutical (RARE) |
United States |
$5.653B |
0.00 |
| SWEDISH ORP BIO (BIOVF) |
Sweden |
$5.550B |
19.89 |
| Sarepta Therapeutics (SRPT) |
United States |
$5.508B |
0.00 |
| NeoGenomics (NEO) |
United States |
$5.447B |
923.80 |
| Exelixis (EXEL) |
United States |
$5.318B |
84.85 |
| Apellis Pharmaceuticals (APLS) |
United States |
$5.123B |
0.00 |
| Adaptive Biotechnologies (ADPT) |
United States |
$5.048B |
0.00 |
| Blueprint Medicines (BPMC) |
United States |
$5.037B |
14.21 |
| Arvinas (ARVN) |
United States |
$4.918B |
0.00 |
| Reata Pharmaceuticals (RETA) |
United States |
$4.659B |
0.00 |
| Vir Biotechnology (VIR) |
United States |
$4.538B |
0.00 |
| Alkermes (ALKS) |
Ireland |
$4.495B |
132.67 |
| AbCellera Biologics (ABCL) |
|
$4.267B |
0.00 |
| Certara (CERT) |
United States |
$4.025B |
0.00 |
| Galapagos (GLPG) |
Belgium |
$3.997B |
0.00 |
| Arena Pharmaceuticals (ARNA) |
United States |
$3.668B |
0.00 |
| ACADIA Pharmaceuticals (ACAD) |
United States |
$3.465B |
0.00 |
| Emergent Biosolutions (EBS) |
United States |
$3.404B |
8.21 |
| Berkeley Lights (BLI) |
United States |
$2.984B |
0.00 |
| Editas Medicine (EDIT) |
United States |
$2.856B |
0.00 |
| Dicerna Pharmaceuticals (DRNA) |
United States |
$2.838B |
0.00 |
| Intra-Cellular Therapies (ITCI) |
United States |
$2.806B |
0.00 |
| Myriad Genetics (MYGN) |
United States |
$2.715B |
0.00 |
| Kymera Therapeutics (KYMR) |
United States |
$2.702B |
0.00 |
| Heska (HSKA) |
United States |
$2.651B |
518.90 |
| BAVARIAN NORDIC (BVNRY) |
Denmark |
$2.623B |
0.00 |
| Insmed (INSM) |
United States |
$2.488B |
0.00 |
| Amicus Therapeutics (FOLD) |
United States |
$2.482B |
0.00 |
| ALX Oncology Holdings (ALXO) |
United States |
$2.475B |
0.00 |
| Sorrento Therapeutics (SRNE) |
United States |
$2.437B |
0.00 |
| Vericel (VCEL) |
United States |
$2.398B |
646.50 |
| Prothena (PRTA) |
Ireland |
$2.390B |
0.00 |
| Atea Pharmaceuticals (AVIR) |
United States |
$2.303B |
0.00 |
| Protagonist Therapeutics (PTGX) |
United States |
$2.165B |
0.00 |
| Revance Therapeutics (RVNC) |
United States |
$2.157B |
0.00 |
| Arcus Biosciences (RCUS) |
United States |
$2.131B |
0.00 |
| Instil Bio (TIL) |
United States |
$2.102B |
0.00 |
| Celldex Therapeutics (CLDX) |
United States |
$2.086B |
0.00 |
| Cytokinetics (CYTK) |
United States |
$2.068B |
0.00 |
| Alector (ALEC) |
United States |
$2.057B |
0.00 |
| C4 Therapeutics (CCCC) |
United States |
$1.984B |
0.00 |
| Morphic Holding (MORF) |
United States |
$1.941B |
0.00 |
| Myovant Sciences (MYOV) |
United Kingdom |
$1.904B |
0.00 |
| Seer (SEER) |
|
$1.902B |
0.00 |
| Ligand Pharmaceuticals (LGND) |
United States |
$1.849B |
27.08 |
| Inovio Pharmaceuticals (INO) |
United States |
$1.803B |
0.00 |
| MorphoSys AG (MOR) |
Germany |
$1.801B |
0.00 |
| Castle Biosciences (CSTL) |
United States |
$1.763B |
0.00 |
| Deciphera Pharmaceuticals (DCPH) |
United States |
$1.711B |
0.00 |
| Amarin (AMRN) |
Ireland |
$1.698B |
0.00 |
| Bluebird Bio (BLUE) |
United States |
$1.694B |
0.00 |
| Global Blood Therapeutics (GBT) |
United States |
$1.674B |
0.00 |
| Bionano Genomics (BNGO) |
United States |
$1.651B |
0.00 |
| PHARMA MAR SA (PHMMF) |
Spain |
$1.585B |
0.00 |
| Avid Bioservices (CDMO) |
United States |
$1.578B |
645.50 |
| ADC Therapeutics SA (ADCT) |
Switzerland |
$1.554B |
0.00 |
| NGM Biopharmaceuticals (NGM) |
United States |
$1.552B |
0.00 |
| Harmony Biosciences Holdings (HRMY) |
United States |
$1.546B |
0.00 |
| Arcturus Therapeutics Holdings (ARCT) |
United States |
$1.533B |
0.00 |
| Nurix Therapeutics (NRIX) |
United States |
$1.493B |
0.00 |
| Y-mAbs Therapeutics (YMAB) |
United States |
$1.491B |
0.00 |
| Zymeworks (ZYME) |
Canada |
$1.475B |
0.00 |
| OXFORD BIOMEDCL (OXBDF) |
United Kingdom |
$1.461B |
0.00 |
| MiMedx (MDXG) |
United States |
$1.405B |
0.00 |
| Ocugen (OCGN) |
United States |
$1.398B |
0.00 |
| Codexis (CDXS) |
United States |
$1.394B |
0.00 |
| Sangamo Therapeutics (SGMO) |
United States |
$1.378B |
0.00 |
| PureTech Health (PRTC) |
United States |
$1.366B |
0.00 |
| REGENXBIO (RGNX) |
United States |
$1.362B |
0.00 |
| UniQure (QURE) |
Netherlands |
$1.353B |
4.60 |
| BioAtla (BCAB) |
United States |
$1.347B |
0.00 |
| Immunocore Holdings (IMCR) |
United Kingdom |
$1.341B |
0.00 |
| Zealand Pharma (ZEAL) |
Denmark |
$1.328B |
0.00 |
| Genetron Holdings (GTH) |
China |
$1.256B |
0.00 |
| Repare Therapeutics (RPTX) |
Canada |
$1.240B |
0.00 |
| Agenus (AGEN) |
United States |
$1.212B |
0.00 |
| Precigen (PGEN) |
United States |
$1.129B |
0.00 |
| Dynavax Technologies (DVAX) |
United States |
$1.116B |
0.00 |
| Forma Therapeutics Holdings (FMTX) |
United States |
$1.109B |
0.00 |
| Nkarta (NKTX) |
United States |
$1.091B |
0.00 |
| Scholar Rock Holding (SRRK) |
United States |
$1.042B |
0.00 |
| Zealand Pharma (ZLDPF) |
Denmark |
$1.035B |
0.00 |
| Inhibrx (INBX) |
United States |
$1.033B |
0.00 |
| Coherus BioSciences (CHRS) |
United States |
$1.001B |
0.00 |
| MannKind (MNKD) |
United States |
$0.994B |
0.00 |
| Northwest Biotherapeutics (NWBO) |
United States |
$0.984B |
0.00 |
| Mesoblast (MESO) |
Australia |
$0.961B |
0.00 |
| Vanda Pharmaceuticals (VNDA) |
United States |
$0.941B |
29.17 |
| KaloBios Pharmaceuticals (HGEN) |
United States |
$0.938B |
0.00 |
| Travere Therapeutics (TVTX) |
United States |
$0.860B |
0.00 |
| Shattuck Labs (STTK) |
United States |
$0.842B |
0.00 |
| Prometheus Biosciences (RXDX) |
United States |
$0.841B |
0.00 |
| Sutro Biopharma (STRO) |
United States |
$0.825B |
0.00 |
| Keros Therapeutics (KROS) |
United States |
$0.810B |
0.00 |
| IDEAYA Biosciences (IDYA) |
United States |
$0.807B |
0.00 |
| VBI Vaccines (VBIV) |
United States |
$0.794B |
0.00 |
| RAPT THERAPTICS (RAPT) |
United States |
$0.778B |
0.00 |
| Kadmon Holdings (KDMN) |
United States |
$0.777B |
0.00 |
| Pliant Therapeutics (PLRX) |
United States |
$0.775B |
0.00 |
| Mersana Therapeutics (MRSN) |
United States |
$0.759B |
0.00 |
| Pharming Group (PHAR) |
Netherlands |
$0.730B |
0.00 |
| Adagene (ADAG) |
China |
$0.728B |
0.00 |
| Pharming Group (PHGUF) |
Netherlands |
$0.720B |
23.00 |
| Avidity Biosciences (RNA) |
United States |
$0.716B |
0.00 |
| Bicycle Therapeutics (BCYC) |
United Kingdom |
$0.714B |
0.00 |
| G1 THERAPEUTICS (GTHX) |
United States |
$0.708B |
0.00 |
| Xenon Pharmaceuticals (XENE) |
Canada |
$0.706B |
0.00 |
| Syndax Pharmaceuticals (SNDX) |
United States |
$0.695B |
0.00 |
| Merus (MRUS) |
Netherlands |
$0.694B |
0.00 |
| SESEN BIO, INC (SESN) |
United States |
$0.691B |
0.00 |
| Affimed (AFMD) |
Germany |
$0.677B |
0.00 |
| Epizyme (EPZM) |
United States |
$0.669B |
0.00 |
| AnaptysBio (ANAB) |
United States |
$0.652B |
0.00 |
| Sinovac Biotech (SVA) |
China |
$0.642B |
6.47 |
| Curis (CRIS) |
United States |
$0.640B |
0.00 |
| Seres Therapeutics (MCRB) |
United States |
$0.638B |
0.00 |
| Cellectis S.A (CLLS) |
France |
$0.619B |
0.00 |
| MeiraGTx Holdings (MGTX) |
United States |
$0.617B |
0.00 |
| Akoya Biosciences (AKYA) |
United States |
$0.615B |
0.00 |
| Nabriva Therapeutics AG (NBRV) |
Ireland |
$0.603B |
0.00 |
| ChromaDex (CDXC) |
United States |
$0.593B |
0.00 |
| Anika Therapeutics (ANIK) |
United States |
$0.588B |
0.00 |
| Cara Therapeutics (CARA) |
United States |
$0.584B |
50.74 |
| Precision BioSciences (DTIL) |
United States |
$0.563B |
0.00 |
| Brooklyn ImmunoTherapeutics (BTX) |
United States |
$0.560B |
0.00 |
| Intercept Pharmaceuticals (ICPT) |
United States |
$0.552B |
0.00 |
| ALBIREO PHARMA (ALBO) |
United States |
$0.547B |
0.00 |
| DBV Technologies S.A (DBVT) |
France |
$0.547B |
0.00 |
| Adaptimmune Therapeutics (ADAP) |
United Kingdom |
$0.541B |
0.00 |
| VistaGen Therapeutics (VTGN) |
United States |
$0.530B |
0.00 |
| Lexicon Pharmaceuticals (LXRX) |
United States |
$0.521B |
9.50 |
| Verastem (VSTM) |
United States |
$0.521B |
0.00 |
| AC Immune SA (ACIU) |
Switzerland |
$0.518B |
0.00 |
| Vaccitech (VACC) |
United Kingdom |
$0.517B |
0.00 |
| Clene (CLNN) |
United States |
$0.508B |
0.00 |
| Clovis Oncology (CLVS) |
United States |
$0.508B |
0.00 |
| Inventiva S.A (IVA) |
France |
$0.507B |
0.00 |
| Basilea Pharmaceutica AG (BPMUF) |
Switzerland |
$0.494B |
0.00 |
| ZIOPHARM Oncology Inc (ZIOP) |
United States |
$0.494B |
0.00 |
| XBiotech (XBIT) |
United States |
$0.484B |
0.00 |
| Cybin (CLXPF) |
Canada |
$0.456B |
0.00 |
| Compugen (CGEN) |
Israel |
$0.451B |
0.00 |
| Bolt Biotherapeutics (BOLT) |
United States |
$0.426B |
0.00 |
| Lineage Cell Therapeutics (LCTX) |
United States |
$0.423B |
0.00 |
| ANI Pharmaceuticals (ANIP) |
United States |
$0.421B |
11.61 |
| Selecta Biosciences (SELB) |
United States |
$0.419B |
0.00 |
| Kindred Biosciences (KIN) |
United States |
$0.419B |
0.00 |
| Oncobiologics (OTLK) |
United States |
$0.418B |
0.00 |
| Athenex (ATNX) |
United States |
$0.415B |
0.00 |
| Spero Therapeutics (SPRO) |
United States |
$0.412B |
0.00 |
| Forte Biosciences (FBRX) |
United States |
$0.405B |
0.00 |
| Starpharma Holdings (SPHRY) |
Australia |
$0.401B |
0.00 |
| Codiak BioSciences (CDAK) |
United States |
$0.393B |
0.00 |
| Autolus Therapeutics (AUTL) |
United Kingdom |
$0.391B |
0.00 |
| Geron (GERN) |
United States |
$0.389B |
0.00 |
| BioDelivery Sciences (BDSI) |
United States |
$0.384B |
15.60 |
| BeyondSpring (BYSI) |
United States |
$0.377B |
0.00 |
| CytomX Therapeutics (CTMX) |
United States |
$0.373B |
0.00 |
| Amryt Pharma (AMYT) |
United Kingdom |
$0.370B |
0.00 |
| XOMA (XOMA) |
United States |
$0.367B |
171.32 |
| Cel-Sci (CVM) |
United States |
$0.355B |
0.00 |
| Orchard Therapeutics (ORTX) |
United Kingdom |
$0.345B |
0.00 |
| SQZ Biotechnologies (SQZ) |
United States |
$0.338B |
0.00 |
| AquaBounty Technologies (AQB) |
United States |
$0.337B |
0.00 |
| Athersys (ATHX) |
United States |
$0.335B |
0.00 |
| Theratechnologies (THTX) |
Canada |
$0.332B |
0.00 |
| Gritstone Bio (GRTS) |
United States |
$0.330B |
0.00 |
| UROGEN PHARMA (URGN) |
United States |
$0.328B |
0.00 |
| Cue Biopharma (CUE) |
United States |
$0.328B |
0.00 |
| Angion Biomedica (ANGN) |
United States |
$0.325B |
0.00 |
| Opthea (OPT) |
Australia |
$0.316B |
0.00 |
| Aeglea BioTherapeutics (AGLE) |
United States |
$0.307B |
0.00 |
| Fortress Biotech (FBIO) |
United States |
$0.306B |
0.00 |
| Clearside Biomedical (CLSD) |
United States |
$0.295B |
0.00 |
| Puma Biotechnology (PBYI) |
United States |
$0.295B |
0.00 |
| ProQR Therapeutics (PRQR) |
Netherlands |
$0.291B |
0.00 |
| Neoleukin Therapeutics (NLTX) |
United States |
$0.288B |
0.00 |
| Frequency Therapeutics (FREQ) |
United States |
$0.284B |
0.00 |
| Syros Pharmaceuticals (SYRS) |
United States |
$0.283B |
0.00 |
| WAVE Life Sciences (WVE) |
Singapore |
$0.280B |
0.00 |
| Prima BioMed (IMMP) |
Australia |
$0.273B |
0.00 |
| IBio (IBIO) |
United States |
$0.268B |
0.00 |
| Innate Pharma S.A (IPHA) |
France |
$0.266B |
0.00 |
| Arbutus Biopharma (ABUS) |
United States |
$0.265B |
0.00 |
| Talis Biomedical (TLIS) |
United States |
$0.260B |
0.00 |
| Cerecor (CERC) |
United States |
$0.258B |
0.00 |
| Kamada (KMDA) |
Israel |
$0.257B |
17.51 |
| OVID THERAPEUTC (OVID) |
United States |
$0.251B |
2.47 |
| Paratek Pharmaceuticals (PRTK) |
United States |
$0.251B |
0.00 |
| EYEPOINT PHARMACEUTICALS, INC (EYPT) |
United States |
$0.246B |
0.00 |
| Kaleido Biosciences (KLDO) |
|
$0.241B |
0.00 |
| Cogent Biosciences (COGT) |
United States |
$0.240B |
0.00 |
| Fulcrum Therapeutics (FULC) |
United States |
$0.238B |
0.00 |
| Chiasma (CHMA) |
United States |
$0.234B |
0.00 |
| INmune Bio (INMB) |
United States |
$0.233B |
0.00 |
| Adicet Bio (ACET) |
United States |
$0.231B |
0.00 |
| Adverum Biotechnologies (ADVM) |
United States |
$0.231B |
0.00 |
| Pieris Pharmaceuticals (PIRS) |
United States |
$0.230B |
0.00 |
| Bellus Health (BLU) |
Canada |
$0.230B |
0.00 |
| CorMedix Inc (CRMD) |
United States |
$0.225B |
0.00 |
| Trevena (TRVN) |
United States |
$0.224B |
0.00 |
| Kala Pharmaceuticals (KALA) |
United States |
$0.223B |
0.00 |
| OSMOTICA PHARM (OSMT) |
United States |
$0.222B |
0.00 |
| Checkpoint Therapeutics (CKPT) |
United States |
$0.204B |
0.00 |
| ADMA Biologics Inc (ADMA) |
United States |
$0.203B |
0.00 |
| NextCure (NXTC) |
United States |
$0.197B |
0.00 |
| TELA Bio (TELA) |
United States |
$0.197B |
0.00 |
| HOOKIPA Pharma (HOOK) |
United States |
$0.194B |
0.00 |
| Cardiff Oncology (CRDF) |
United States |
$0.193B |
0.00 |
| Beyond Air (XAIR) |
United States |
$0.183B |
0.00 |
| AVEO Pharmaceuticals (AVEO) |
United States |
$0.179B |
0.00 |
| GENFIT S.A (GNFT) |
France |
$0.179B |
0.00 |
| Biofrontera AG (BFRA) |
Germany |
$0.178B |
0.00 |
| VolitionRX (VNRX) |
United States |
$0.175B |
0.00 |
| Aptinyx (APTX) |
United States |
$0.172B |
0.00 |
| Nicox SA (NICXF) |
France |
$0.171B |
0.00 |
| POXEL SA FRANCE (PXXLF) |
France |
$0.170B |
0.00 |
| Erytech Pharma SA (ERYP) |
France |
$0.168B |
0.00 |
| Seelos Therapeutics (SEEL) |
United States |
$0.164B |
0.00 |
| Strongbridge Biopharma (SBBP) |
United States |
$0.160B |
0.00 |
| PHASEBIO PHARMA (PHAS) |
United States |
$0.160B |
0.00 |
| Enzo Biochem (ENZ) |
United States |
$0.159B |
47.00 |
| VTv Therapeutics (VTVT) |
United States |
$0.158B |
0.00 |
| Applied Genetic Technologies (AGTC) |
United States |
$0.155B |
0.00 |
| Synlogic (SYBX) |
United States |
$0.152B |
0.00 |
| ObsEva SA (OBSV) |
Switzerland |
$0.144B |
0.00 |
| Eton Pharmaceuticals (ETON) |
United States |
$0.142B |
0.00 |
| X4 Pharmaceuticals (XFOR) |
United States |
$0.140B |
0.00 |
| LogicBio Therapeutics (LOGC) |
United States |
$0.137B |
0.00 |
| Purple Biotech (PPBT) |
Israel |
$0.137B |
0.00 |
| Galena Biopharma (SLS) |
United States |
$0.137B |
0.00 |
| Exicure (XCUR) |
United States |
$0.134B |
0.00 |
| Cyclerion Therapeutics (CYCN) |
United States |
$0.134B |
0.00 |
| Catalyst Biosciences (CBIO) |
United States |
$0.127B |
0.00 |
| ANIXA BIOSCIENCES INC (ANIX) |
United States |
$0.127B |
0.00 |
| Entera Bio (ENTX) |
Israel |
$0.125B |
0.00 |
| Abeona Therapeutics (ABEO) |
United States |
$0.125B |
0.00 |
| Voyager Therapeutics (VYGR) |
United States |
$0.124B |
3.19 |
| Orgenesis (ORGS) |
United States |
$0.123B |
250.50 |
| Viridian Therapeutics (VRDN) |
United States |
$0.122B |
0.00 |
| Liquidia Technologies (LQDA) |
United States |
$0.120B |
0.00 |
| Palatin Technologies (PTN) |
United States |
$0.118B |
0.00 |
| Novogen (KZIA) |
Australia |
$0.115B |
0.00 |
| Longeveron (LGVN) |
United States |
$0.108B |
0.00 |
| Eyenovia (EYEN) |
United States |
$0.108B |
0.00 |
| ASLAN Pharmaceuticals (ASLN) |
Singapore |
$0.108B |
0.00 |
| Cocrystal Pharma (COCP) |
United States |
$0.107B |
0.00 |
| F-star Therapeutics (FSTX) |
United Kingdom |
$0.105B |
0.00 |
| Pluristem Therapeutics (PSTI) |
Israel |
$0.104B |
0.00 |
| Yumanity Therapeutics (YMTX) |
United States |
$0.102B |
0.00 |
| Vascular Biogenics (VBLT) |
Israel |
$0.101B |
0.00 |
| Aytu BioPharma (AYTU) |
United States |
$0.098B |
0.00 |
| Aerpio Pharmaceuticals (ARPO) |
United States |
$0.096B |
0.00 |
| Celsion (CLSN) |
United States |
$0.093B |
0.00 |
| Dyadic (DYAI) |
United States |
$0.092B |
0.00 |
| Leap Therapeutics (LPTX) |
United States |
$0.091B |
0.00 |
| Liminal BioSciences (LMNL) |
Canada |
$0.088B |
0.00 |
| ARAVIVE, INC (ARAV) |
United States |
$0.088B |
0.00 |
| AEterna Zentaris (AEZS) |
United States |
$0.086B |
0.00 |
| Cidara Therapeutics (CDTX) |
United States |
$0.083B |
0.00 |
| Evofem Biosciences (EVFM) |
United States |
$0.082B |
0.00 |
| Zosano Pharma (ZSAN) |
United States |
$0.081B |
0.00 |
| Aptevo Therapeutics (APVO) |
United States |
$0.080B |
0.00 |
| Stealth BioTherapeutics (MITO) |
Cayman Islands |
$0.079B |
0.00 |
| Vyant Bio (VYNT) |
United States |
$0.078B |
0.00 |
| Adocia (ADOCY) |
France |
$0.077B |
0.00 |
| AIkido Pharma (AIKI) |
United States |
$0.075B |
0.00 |
| Evogene (EVGN) |
Israel |
$0.075B |
0.00 |
| Emmaus Life Sciences (EMMA) |
United States |
$0.074B |
0.00 |
| ATyr Pharma (LIFE) |
United States |
$0.073B |
0.00 |
| Protalix BioTherapeutics (PLX) |
Israel |
$0.072B |
0.00 |
| Vaccinex (VCNX) |
United States |
$0.070B |
0.00 |
| Organovo Holdings (ONVO) |
United States |
$0.066B |
0.00 |
| Celyad SA (CYAD) |
Belgium |
$0.066B |
0.00 |
| Lumos Pharma (LUMO) |
United States |
$0.064B |
0.00 |
| Edesa Biotech (EDSA) |
Canada |
$0.063B |
0.00 |
| Advaxis (ADXS) |
United States |
$0.063B |
0.00 |
| DiaMedica Therapeutics (DMAC) |
United States |
$0.062B |
0.00 |
| Alimera Sciences (ALIM) |
United States |
$0.059B |
0.00 |
| BioCardia (BCDA) |
United States |
$0.059B |
0.00 |
| Idera Pharmaceuticals (IDRA) |
United States |
$0.056B |
0.00 |
| Cytocom (CBLI) |
United States |
$0.055B |
0.00 |
| Windtree Therapeutics (WINT) |
United States |
$0.053B |
0.00 |
| Genetic Technologies (GENE) |
Australia |
$0.053B |
0.00 |
| TRACON Pharmaceuticals (TCON) |
United States |
$0.053B |
0.00 |
| Cyclo Therapeutics (CYTH) |
United States |
$0.053B |
0.00 |
| ARIDIS PHARMACT (ARDS) |
United States |
$0.050B |
0.00 |
| AnPac Bio-Medical Science (ANPC) |
China |
$0.049B |
0.00 |
| Cyclacel Pharmaceuticals (CYCC) |
United States |
$0.046B |
0.00 |
| Invo BioScience (INVO) |
United States |
$0.046B |
0.00 |
| Pulmatrix (PULM) |
United States |
$0.046B |
0.00 |
| Enveric Biosciences (ENVB) |
United States |
$0.041B |
0.00 |
| Happiness Biotech Group (HAPP) |
China |
$0.041B |
0.00 |
| Soligenix (SNGX) |
United States |
$0.039B |
0.00 |
| Timber Pharmaceuticals (TMBR) |
United States |
$0.037B |
0.00 |
| Acorda Therapeutics (ACOR) |
United States |
$0.037B |
0.89 |
| Lexaria Bioscience (LEXX) |
Canada |
$0.033B |
0.00 |
| Prana Biotechnology (ATHE) |
Australia |
$0.031B |
0.00 |
| Vallon Pharmaceuticals (VLON) |
United States |
$0.031B |
0.00 |
| ThermoGenesis Holdings (THMO) |
United States |
$0.029B |
0.00 |
| PLANET GREEN HOLDINGS CORP (PLAG) |
China |
$0.028B |
0.00 |
| Benitec Biopharma (BNTC) |
United States |
$0.028B |
0.00 |
| IMMURON (IMRN) |
Australia |
$0.028B |
0.00 |
| GeoVax Labs (GOVX) |
United States |
$0.027B |
0.00 |
| Sonnet BioTherapeutics Holdings (SONN) |
United States |
$0.027B |
0.00 |
| Titan Pharmaceuticals (TTNP) |
United States |
$0.023B |
0.00 |
| ZIVO Bioscience (ZIVO) |
United States |
$0.018B |
0.00 |
| Palisade Bio (PALI) |
United States |
$0.008B |
0.00 |
| CollPlant Biotechnologies (CLGN) |
Israel |
$0.000B |
0.00 |
| ImmunityBio (IBRX) |
United States |
$0.000B |
0.00 |
| Immatics (IMTX) |
Germany |
$0.000B |
0.00 |
| PDL BioPharma (PDLI) |
United States |
$0.000B |
0.00 |
